The Value of Offering Oncofertility Counseling in Young Patients With Newly Diagnosed Cancer Is Unquestionable

We have read with some concerns the narrative review recently published by Eden et al1 addressing important questions in the field of oncofertility, including the gonadotoxicity of anticancer treatments, the uptake of fertility preservation strategies among young patients with cancer, and their effectiveness. The authors questioned the validity of the evidence surrounding fertility preservation, advocating for the need of stronger evidence (particularly deriving from randomized trials) before considering this approach recommendable. As strong advocates for the unquestionable relevance of offering a proper oncofertility counseling to young patients with newly diagnosed cancer, we would like to take the opportunity to rectify some points reported in the review.